LNG Patch
Alternative Name: Levonorgestrel (LNG)-only patch; AG890
Description: A low-dose, progestin-only contraceptive patch. It has been tested at two doses: 75mg/day and 40mg/day.
Product Details
User: Female
Hormonal: Yes
Delivery Method: Transdermal
Duration Type: Short-acting
Duration: One week
Regimen: - Replaced every 7 days in a continuous 28-day regimen with no patch-free interval
- Replaced every 7 days in a continuous 28-day regimen with no patch-free interval
Dose: 75mg/day or 40mg/day
Active Pharmaceutical Ingredient (API): - levonorgestrel
- levonorgestrel
Multipurpose Preventive Technology (MPT): No
Status Details
Developer: Agile Therapeutics
Project Phase: Pre-Clinical and Clinical Development
Development Stage: Phase II
Active Development: Yes
Status Details: - Phase II study to evaluate pharmacokinetics and safety has been completed.
- Phase II study to evaluate pharmacokinetics and safety has been completed.
Additional Information
References: Agile Therapeutics website: https://www.agiletherapeutics.com
Clinicaltrials.gov Identified NCT01623466
Westhoff CL, et al. (2018) Phase I/II pharmacokinetic and pharmacodynamic evaluation of two levonorgestrel-only contraceptive patches in a multicenter randomized trial. Contraception. 98(2);151-157.
Agile Therapeutics website: https://www.agiletherapeutics.com
Clinicaltrials.gov Identified NCT01623466
Westhoff CL, et al. (2018) Phase I/II pharmacokinetic and pharmacodynamic evaluation of two levonorgestrel-only contraceptive patches in a multicenter randomized trial. Contraception. 98(2);151-157.